LEADER 04091nam  22006135  450 
001 9910253889503321
005 20200629223404.0
010   $a981-10-0818-3
024 7 $a10.1007/978-981-10-0818-4
035   $a(CKB)3710000000722399
035   $a(DE-He213)978-981-10-0818-4
035   $a(MiAaPQ)EBC4538561
035   $a(PPN)194377032
035   $a(EXLCZ)993710000000722399
100   $a20160604d2016      u|         0
101 0 $aeng
135   $aurnn|008mamaa
181   $ctxt$2rdacontent
182   $cc$2rdamedia
183   $acr$2rdacarrier
200 10$aNanoscale Materials in Targeted Drug Delivery, Theragnosis and Tissue Regeneration /$fedited by Sudesh Kumar Yadav
205   $a1st ed. 2016.
210  1$aSingapore :$cSpringer Singapore :$cImprint: Springer,$d2016.
215   $a1 online resource (XIX, 172 p. 11 illus., 10 illus. in color.) 
311   $a981-10-0817-5 
320   $aIncludes bibliographical references.
327   $a1. Nanoscale materials in targeted drug delivery -- 2. Biodegradable nanoparticles and their in vivo fate -- 3. Metallic nanoparticles, toxicity issues and applications in medicine -- 4. Liposomal and phytosomal formulations -- 5. Nanocellulose and nanocomposites -- 6. Theragnosis: Nanoparticles as a tool for simultaneous therapy and diagnosis -- 7. Cellular response of therapeutic nanoparticles.
330   $aThis book is the first of its kind to offer a comprehensive and up-to-date discussion of the use of nanoscale materials for biomedical applications, with a particular focus on drug delivery, theragnosis and tissue regeneration. It also describes in detail the methods used in the preparation of nanoparticles. Response of nanoparticles in biological systems are also explored. Nanotechnology has led to the advent of a new field, nanomedicine, which focuses on the use of nanomaterials as drug-delivery vehicles to develop highly selective and effective drugs. The combination of molecular imaging and nanotechnology has produced theragnostic nanoparticles, which allow the simultaneous detection and monitoring of diseases. Nanotechnology can also be combined with biomaterials to create scaffolds for tissue regeneration. Further, significant advances have been made in the areas of drug delivery, theragnostic nanoparticles and tissue regeneration materials. Some nanomedicines and tissue regeneration materials are already commercially available, while others are undergoing clinical trials, and promising results have been documented. Despite the rapid advances in nanomedicine, there is a relative dearth of literature on the biomedical applications of nanoscale materials.
606   $aBiomedical engineering
606   $aNanotechnology
606   $aPharmacology
606   $aPharmacotherapy
606   $aGenetic engineering
606   $aBiomedical Engineering/Biotechnology$3https://scigraph.springernature.com/ontologies/product-market-codes/B24000
606   $aNanotechnology and Microengineering$3https://scigraph.springernature.com/ontologies/product-market-codes/T18000
606   $aPharmacology/Toxicology$3https://scigraph.springernature.com/ontologies/product-market-codes/B21007
606   $aPharmacotherapy$3https://scigraph.springernature.com/ontologies/product-market-codes/H69000
606   $aGenetic Engineering$3https://scigraph.springernature.com/ontologies/product-market-codes/C12037
615  0$aBiomedical engineering.
615  0$aNanotechnology.
615  0$aPharmacology.
615  0$aPharmacotherapy.
615  0$aGenetic engineering.
615 14$aBiomedical Engineering/Biotechnology.
615 24$aNanotechnology and Microengineering.
615 24$aPharmacology/Toxicology.
615 24$aPharmacotherapy.
615 24$aGenetic Engineering.
676   $a610.28
702   $aYadav$b Sudesh Kumar$4edt$4http://id.loc.gov/vocabulary/relators/edt
906   $aBOOK
912   $a9910253889503321
996   $aNanoscale Materials in Targeted Drug Delivery, Theragnosis and Tissue Regeneration$92541157
997   $aUNINA